Alzheimer Europe’s July-August 2021 newsletter brings you the latest news on developments in the dementia field, across Europe and beyond.
Summaries of a few of our top stories appear below.
Our monthly newsletter reaches around 11,000 people and we are always happy to receive feedback, or suggestions regarding news items to share in future issues.
Alzheimer Europe is delighted to welcome Claudia Gamon MEP (Renew Europe, Austria) to the European Alzheimer’s Alliance. Her taking the number of MEPs in the Alliance to 93 members from 26 countries.
Alzheimer Europe and a coalition of EU Health NGOs launched a social media campaign to #SaveEUHealthNGOs, asking the European Commission to restore operating grants in the EU4Health Programme in order to support core activities of European NGOs.
A group of researchers has published a new paper on the global prevalence of Young-Onset Dementia in the journal JAMA Neurology. This important research aims to provide policy makers with much needed information to organise health care in an appropriate way as the rates indicate the condition to be more prevalent than previously thought.
The Alzheimer’s Association International Conference (AAIC) 2021 took place in Denver, US and online, between 26 and 30 July. We provide some links to our selected highlights about the event and the research presented.
The final selection of abstracts for our virtual 31st Annual Conference #31AEC was made during July 2021 and notifications have been sent to all applicants. Our committee has reviewed all submitted abstracts and selected 59 oral presentations, 139 quick oral and 39 posters.
There is a lack of equity in relation to dementia diagnoses and care because equal opportunities do not necessarily translate into equal outcomes. Our expert ethics working group has produced an extensive report on this issue, a policy brief and a guide for health and social care workers. The authors present some of the key challenges and recommendations for healthcare clinicians striving to provide timely diagnosis and good quality care and treatment to people with dementia from all ethnic groups.
This newsletter received funding under an operating grant from the European Union’s Health Programme (2014-2020).
The content of this newsletter represents the views of the author only and is his/her sole responsibility; it cannot be considered to reflect the views of the European Commission and/or the Consumers, Health, Agriculture and Food Executive Agency or any other body of the European Union. The European Commission and the Agency do not accept any responsibility for use that may be made of the information it contains.